Status:
COMPLETED
Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients
Lead Sponsor:
Peking University
Conditions:
Deep Sedation
Dexmedetomidine
Eligibility:
All Genders
3-7 years
Phase:
PHASE4
Brief Summary
It is important to choose an appropriate analgesia/sedation technique in pediatric dental treatment. Premedication combined with intravenous anesthesia is often used in deep sedation technique for ped...
Eligibility Criteria
Inclusion
- children in need of deep sedation for dental treatment aged 3-7 years.
- anticipated operation time 1-2hours
Exclusion
- any known medical records with neural or mental disorder
- any known medical records with severe systemic disorder
- history of sedation drug administration in recent 1 months
- any known allergic history of dexmedetomidine, midazolam or propofol
- morbid obesity
- history of OSAHS or acute respiratory infection in 2 weeks
- other conditions which the attending considers to be unfit for the trial
Key Trial Info
Start Date :
April 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04509414
Start Date
April 10 2020
End Date
May 31 2022
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Hospital of Stomatology
Beijing, Beijing Municipality, China, 100081